The Cooper Companies, Inc. (COO)

NASDAQ: COO · Real-Time Price · USD

81.40

+4.37 (5.67%)

At close: Dec 5, 2025, 4:00 PM EST

80.89

-0.51 (-0.63%)

After-hours: Dec 5, 2025, 7:55 PM EST

Revenue

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	2012 - 2021
Toric Lens Revenue	-	Log In	Log In	Log In	Upgrade
Multifocal Lens Revenue	-	Log In	Log In	Log In	Upgrade
Toric and Multifocal Revenue	1.35B	Log In	Log In	Log In	Upgrade
Single-Use Sphere Lens Revenue	-	Log In	Log In	Log In	Upgrade
Non Single-Use Sphere Lens and Other Revenue	-	Log In	Log In	Log In	Upgrade
Sphere, Other Revenue	1.39B	Log In	Log In	Log In	Upgrade
Total CooperVision Revenue	2.74B	Log In	Log In	Log In	Upgrade
Office and Surgical Products Revenue	824.00M	Log In	Log In	Log In	Upgrade
Fertility Revenue	524.60M	Log In	Log In	Log In	Upgrade
Total CooperSurgical Revenue	1.35B	Log In	Log In	Log In	Upgrade
Revenue (Other)	-2.74B	Log In	Log In	Log In	Upgrade
Revenue (Total)	4.09B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	2012 - 2021
United States Revenue	2.05B	Log In	Log In	Log In	Upgrade
Europe Revenue	1.25B	Log In	Log In	Log In	Upgrade
Rest Of The World Revenue	785.20M	Log In	Log In	Log In	Upgrade
Revenue (Total)	4.09B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	2012 - 2021
CooperVision Operating Income	729.60M	Log In	Log In	Log In	Upgrade
CooperSurgical Operating Income	43.40M	Log In	Log In	Log In	Upgrade
Corporate Operating Income	-90.10M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	682.90M	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	2012 - 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	2012 - 2021
CooperVision - Constant Currency Revenue Growth	5.00%	Log In	Log In	Log In	Upgrade
CooperSurgical - Constant Currency Revenue Growth	5.00%	Log In	Log In	Log In	Upgrade
Total Company - Constant Currency Revenue Growth	5.00%	Log In	Log In	Log In	Upgrade
CooperVision - Organic Revenue Growth	5.00%	Log In	Log In	Log In	Upgrade
CooperSurgical - Organic Revenue Growth	3.00%	Log In	Log In	Log In	Upgrade
Total Company - Organic Revenue Growth	4.00%	Log In	Log In	Log In	Upgrade

Updated Dec 4, 2025. Data Source: Fiscal.ai.